Solid Biosciences

Solid Biosciences will be presenting at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference, in Dallas, Texas, on Wednesday, March 19 at 1:45 PM CT / 2:45 PM ET. ? Learn more: https://lnkd.in/eqMANYt2 #MDAConference #DuchenneMuscularDystrophy #Duchenne #Neuromuscular #SolidBiosciences

Solid Biosciences is pleased to announce our financial results for the fourth quarter and full year 2024, along with business updates. Read the full release: https://lnkd.in/eBvFVTeV #SolidBiosciences

Solid will be participating in upcoming investor conferences, where President & CEO, Bo Cumbo, and CMO, Gabriel Brooks, M.D., will partake in fireside chats. - Leerink Partners Global Healthcare Conference: March 12, at 9:20 AM ET - Barclays 27th Annual Global Healthcare Conference: March 13, at 9:30 AM ET Tune in via live webcasts: https://lnkd.in/eJXs83j Solid is also a participating in Wedbush Securities’ Cardiometabolic Conference on Monday, March 10 in Miami, Florida. #SolidBiosciences #GeneticMedicines #HealthcareInnovation #Biotech #Leerink #Barclays #WedbushSecurities

Join us tomorrow, March 4, for a webinar with Defeat Duchenne Canada as we discuss the initial positive data from the INSPIRE DUCHENNE study on SGT-003, a next-generation microdystrophin gene therapy. ? Gabriel Brooks, MD, Chief Medical Officer, Annie Ganot, Co-founder and Head of Patient Advocacy, Patrick Gonzalez, PhD, Senior Director, Clinical Science, and Matthew Harmelink, MD, Therapeutic Area Head, Neuromuscular will provide an update on the study, including microdystrophin expression and biomarker results from participants who have reached the Day 90 timepoint, as well as a safety update from the first six participants dosed. ? Register now: https://lnkd.in/eSvbFvRZ #Duchenne #DuchenneMuscularDystrophy #DuchenneCommunity #GeneTherapy #DefeatDuchenne

Members of the Solid Biosciences team recently joined PPMD for a community webinar to review initial positive data from the INSPIRE DUCHENNE study of SGT-003, a next-generation microdystrophin gene therapy candidate. Watch the recording: https://lnkd.in/efKtQ-dZ

Today?is?Rare?Disease?Day, a?day?dedicated to raising awareness and driving change for the 300 million people worldwide living with a?rare?disease, along with their families and caregivers. ? The zebra is the official symbol of rare disease. We show our stripes on this day to represent the uniqueness and strength of those living with rare conditions. A special thank you to Hood Park Charlestown for illuminating the Hood Park smokestack in blue to #LightUpForRare. ? Every?day, Solid strives to advance meaningful science and create a lasting impact for individuals and families living with?rare?diseases. Today, we reaffirm our commitment to the?rare?disease?community and to our mission of improving lives. ? Join us in spreading awareness and advocating for change.?National Organization for Rare Disorders Rare Disease Day #RareDiseaseDay?#RDD2025 #ShowYourStripes #RareDiseaseResearch

The Solid team had an amazing weekend hitting the slopes at Loon Mountain Resort for the New England Disabled Sports (NEDS) "Coach for A Day" event! Our coaches trained alongside the NEDS team, helping athletes experience the fun of adaptive skiing and snowboarding. A huge thanks to JB’s Keys for pairing our coaches with athletes from the #Duchenne community. #TeamSolid is grateful for the opportunity to work with the inspiring students at NEDS. Here’s to another incredible weekend of teaching and learning in the snow. ???? #AdaptiveSports #NewEnglandDisabledSports #DuchenneCommunity

Solid Biosciences is proud to sponsor?Parent Project aps’s XXII International Conference on Duchenne and Becker Muscular Dystrophy, taking place February 28 - March 2, in Rome at the Ergife Palace Hotel. ? Our Head of Patient Advocacy and Co-Founder,?Annie Ganot, and?Patrick Gonzalez, PhD, Senior Director, Clinical Science, will be attending. Join us in Rome to connect, learn, and drive progress in the Duchenne and Becker communities:?https://lnkd.in/efzW_9uu #Duchenne #GeneTherapy #ParentProjectAPS #DuchenneCommunity????

Solid Biosciences is proud to sponsor Jett Foundation’s 8th Annual Rare Disease Day event on February 28, 2025! This special panel discussion, moderated by Sean Baumstark and Kyle Bryant of the Two Disabled Dudes Podcast, will highlight members of our community who are thriving through adaptive experiences and adaptive living. Don't miss out, register today: https://lnkd.in/ehCdh7JB #RareDiseaseDay #Duchenne #RareDisease #JettFoundation

Solid will be joining Parent Project Muscular Dystrophy on Tuesday, February 25, at 1 PM ET to review positive initial data from the INSPIRE DUCHENNE study of SGT-003, our next-generation microdystrophin gene therapy candidate. ? Members of the Solid team, including Gabriel Brooks, MD, Chief Medical Officer, Patrick Gonzalez, PhD, Senior Director, Clinical Science, Annie Ganot, Co-founder, Head of Patient Advocacy, and Matthew Harmelink, MD, Therapeutic Area Head, Neuromuscular, will discuss the recent study update, including microdystrophin expression and biomarker results from three?participants who have reached the Day 90 timepoint. A safety update from the first six participants dosed will be outlined, as well as plans for continued dosing in the phase 1/2 study. ? Register to attend and submit questions in advance using the following link: https://lnkd.in/eq2HPqnt ? #SolidBiosciences #DuchenneMuscularDystrophy #Duchenne #DuchenneCommunity #GeneTherapy #RareDiseaseResearch